These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Usefulness of a serological panel test in the assessment of gastritis in symptomatic children. de Angelis GL, Cavallaro LG, Maffini V, Moussa AM, Fornaroli F, Liatopoulou S, Bizzarri B, Merli R, Comparato G, Caruana P, Cavestro GM, Franzé A, Di Mario F. Dig Dis; 2007; 25(3):206-13. PubMed ID: 17827941 [Abstract] [Full Text] [Related]
3. Do children and adolescents with type 1 diabetes mellitus have a higher frequency of parietal cell antibodies than healthy controls? Fröhlich-Reiterer EE, Huber J, Katz H, Suppan E, Obermayer-Pietsch B, Deutschmann A, Demel U, Acham-Roschitz B, Weinhandl G, Ambros-Rudolph CM, Hauer A, Borkenstein MH. J Pediatr Gastroenterol Nutr; 2011 May; 52(5):558-62. PubMed ID: 21502826 [Abstract] [Full Text] [Related]
11. Relation of parietal cell and thyroid antibodies to the state of gastric mucosa and basal serum gastrin levels during a 6-year follow up. Uibo R, Krohn K, Villako K, Tammur R, Tamm A. Clin Exp Immunol; 1989 Aug; 77(2):202-5. PubMed ID: 2776358 [Abstract] [Full Text] [Related]
14. Anti-parietal cell antibody and serum pepsinogen assessment in screening for gastric carcinoma. Sugiu K, Kamada T, Ito M, Kaya S, Tanaka A, Kusunoki H, Hata J, Haruma K. Dig Liver Dis; 2006 May; 38(5):303-7. PubMed ID: 16549394 [Abstract] [Full Text] [Related]
15. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies. Cao Q, Ran ZH, Xiao SD. J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130 [Abstract] [Full Text] [Related]
16. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients. Ohkusa T, Miwa H, Nomura T, Asaoka D, Kurosawa A, Sakamoto N, Abe S, Hojo M, Terai T, Ogihara T, Sato N. Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602 [Abstract] [Full Text] [Related]
17. Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacterpylori antibodies in the management of dyspeptic patients in primary care. Germaná B, Di Mario F, Cavallaro LG, Moussa AM, Lecis P, Liatoupolou S, Comparato G, Carloni C, Bertiato G, Battiestel M, Papa N, Aragona G, Cavestro GM, Iori V, Merli R, Bertolini S, Caruana P, Franzé A. Dig Liver Dis; 2005 Jul; 37(7):501-8. PubMed ID: 15975537 [Abstract] [Full Text] [Related]
18. Helicobacter pylori serology in patients with chronic gastritis. Plebani M, Basso D, Cassaro M, Brigato L, Scrigner M, Toma A, Di Mario F, Rugge M. Am J Gastroenterol; 1996 May; 91(5):954-8. PubMed ID: 8633587 [Abstract] [Full Text] [Related]
19. Helicobacter pylori infection is the major risk factor for atrophic gastritis. Kawaguchi H, Haruma K, Komoto K, Yoshihara M, Sumii K, Kajiyama G. Am J Gastroenterol; 1996 May; 91(5):959-62. PubMed ID: 8633588 [Abstract] [Full Text] [Related]
20. Serum gastrin, pepsinogens, parietal cell and Helicobacter pylori antibodies in patients with gastric polyps. Bonilla Palacios JJ, Miyazaki Y, Kanayuma S, Yasunaga Y, Matsuzawa Y. Acta Gastroenterol Latinoam; 1994 May; 24(2):77-82. PubMed ID: 7817697 [Abstract] [Full Text] [Related] Page: [Next] [New Search]